C07D 491/02
In which the condensed system contains two hetero rings
Official title: in which the condensed system contains two hetero rings
C07D491/02 (In which the condensed system contains two hetero rings) appears on 7,817 US grants and 8,874 published applications in this corpus.
Search patents in C07D- Granted patents
- 7,817
- Published applications
- 8,874
- Assignees
- 2,569
- Inventors
- 22,750
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 52 | 0 |
| 1977 | 51 | 0 |
| 1978 | 47 | 0 |
| 1979 | 43 | 0 |
| 1980 | 48 | 0 |
| 1981 | 69 | 0 |
| 1982 | 46 | 0 |
| 1983 | 61 | 0 |
| 1984 | 60 | 0 |
| 1985 | 59 | 0 |
| 1986 | 76 | 0 |
| 1987 | 74 | 0 |
| 1988 | 69 | 0 |
| 1989 | 74 | 0 |
| 1990 | 51 | 0 |
| 1991 | 66 | 0 |
| 1992 | 74 | 0 |
| 1993 | 69 | 0 |
| 1994 | 60 | 0 |
| 1995 | 79 | 0 |
| 1996 | 110 | 0 |
| 1997 | 128 | 0 |
| 1998 | 103 | 0 |
| 1999 | 104 | 0 |
| 2000 | 109 | 0 |
| 2001 | 132 | 37 |
| 2002 | 154 | 133 |
| 2003 | 144 | 245 |
| 2004 | 144 | 300 |
| 2005 | 116 | 260 |
| 2006 | 184 | 278 |
| 2007 | 139 | 278 |
| 2008 | 145 | 247 |
| 2009 | 174 | 293 |
| 2010 | 205 | 329 |
| 2011 | 192 | 332 |
| 2012 | 225 | 313 |
| 2013 | 308 | 364 |
| 2014 | 309 | 390 |
| 2015 | 321 | 398 |
| 2016 | 286 | 419 |
| 2017 | 344 | 363 |
| 2018 | 292 | 382 |
| 2019 | 351 | 397 |
| 2020 | 283 | 457 |
| 2021 | 288 | 382 |
| 2022 | 289 | 420 |
| 2023 | 249 | 557 |
| 2024 | 274 | 508 |
| 2025 | 309 | 456 |
| 2026 | 178 | 336 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Organic compound, light-emitting device, light-emitting apparatus, electronic appliance, and lighting device6 Oct 2026US 12,753,182 B2Semiconductor Energy Laboratory Co.Ltd.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystalline forms of a parp1 inhibitor8 Oct 2026US 2026/0308163 A1Gilead Sciences, Inc.
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Brm selective degradation agent and use thereof8 Oct 2026US 2026/0308165 A1
- Oxadiazolyl dihydropyrano[2,3-b]pyridine inhibitors of hipk2 for treating kidney fibrosis8 Oct 2026US 2026/0308166 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Methods for repairing damaged intervertebral discs571US 6,602,248 B1Arthro Care Corporation · 2003
- Methods for repairing damaged intervertebral discs418US 7,318,823 B2ArthroCare Corporation · 2008
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Apoptosis promoters226US 7,390,799 B2Abbott Laboratories · 2008
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997